A Study of AMC6156 in People With Sarcopenia

NCT07072195 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Sarcopenia in Elderly
Sarcopenia

Interventions

DRUG: AMC6156 0.1mg
DRUG: AMC6156 0.3mg
DRUG: AMC6156 1.0mg
DRUG: Placebo

Sponsor

Animuscure Inc.